Marinus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRNS and other ETFs, options, and stocks.

About MRNS

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.

CEO

Scott N. Braunstein

CEOScott N. Braunstein

Employees

165

Employees165

Headquarters

Radnor, Pennsylvania

HeadquartersRadnor, Pennsylvania

Founded

2003

Founded2003

Employees

165

Employees165

MRNS Key Statistics

Market cap

79.23M

Market cap79.23M

Price-Earnings ratio

-0.55

Price-Earnings ratio-0.55

Dividend yield

—

Dividend yield—

Average volume

8.44M

Average volume8.44M

High today

$1.52

High today$1.52

Low today

$1.39

Low today$1.39

Open price

$1.44

Open price$1.44

Volume

1.65M

Volume1.65M

52 Week high

$11.26

52 Week high$11.26

52 Week low

$1.11

52 Week low$1.11

MRNS News

TipRanks 7d

Biotech Alert: Searches spiking for these stocks today - TipRanks.com - TipRanks

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key...

Analyst ratings

73%

of 11 ratings

Buy

72.7%

Hold

27.3%

Sell